PR Newswire (press release) On May 29, 2013, Actavis Inc. (Actavis) launched Zoledronic Acid Actavis 4mg/5ml concentrate for solution for infusion in 14 European markets. The product was first to market in Germany, Spain, Sweden, Romania and Austria on Friday, May 17, 2013 and ... and more »
MarketWatch (press release) Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid . ... (Dasatinib) 61Gleevec/Glivec (Imatinib Mesylate) 61Cerezyme (Imiglucerase) 61Thalomid (Thalidomide ... and more »
IAM (registration) (blog) The UK Court of Appeal has reversed an earlier decision of the High Court and granted Novartis a preliminary injunction against Hospira, preventing sales of generic zoledronic acid for treating osteoporosis ([2013] EWCA Civ 583). The decision provides ... and more »
The Herald | HeraldOnline.com Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid . ... Zometa/Zomera/Aclasta/Reclast ( Zoledronic or Zoledronate) 63 MARKET REVENUE 63 TABLE 11 GLOBAL SALES ... and more »
CNN (blog) Use of the bone drug zoledronic acid , made by the drug company Novartis, was found to be effective only in postmenopausal women. "It's probably not going to work for women who are premenopausal," says lead study author Dr. Adam Brufsky. "You should ...
MarketWatch (press release) On May 29, 2013, Actavis Inc. (Actavis) launched Zoledronic Acid Actavis 4mg/5ml concentrate for solution for infusion in 14 European markets. The product was first to market in Germany, Spain, Sweden, Romania and Austria on Friday, May 17, 2013 and ... and more »
PR Newswire (press release) On May 29, 2013, Actavis Inc. (Actavis) launched Zoledronic Acid Actavis 4mg/5ml concentrate for solution for infusion in 14 European markets. The product was first to market in Germany, Spain, Sweden, Romania and Austria on Friday, May 17, 2013 and ... and more »
